LLNL, UC Davis Partner to Personalize Cancer Medications

News   Oct 29, 2014

 
LLNL, UC Davis Partner to Personalize Cancer Medications
 
 
 

RELATED ARTICLES

Cancer Stem Cell Survival is Controlled by Hedgehog Signaling Proteins

News

Research reveals that cancer stem cell survival is controlled by a specific feature of the Hedgehog signaling pathway (SHH-PTCH1), which allows cells to respond to external signals in addition to inhibiting stem cell differentiation.

READ MORE

Meteorite Dust Charts History of the Solar System

News

Using a state-of-the-art mass spectrometer to measure the titanium isotopes in supernova SiC grains, scientists have been able to test theoretical calculations about the origins of the solar system.

READ MORE

Single Blood Test 'CancerSEEK' Screens for Eight Cancer Types

News

Johns Hopkins Kimmel Cancer Center researchers developed a single blood test that screens for eight common cancer types and helps identify the location of the cancer.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cancer Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE